KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Debt Ratio (2019 - 2025)

Vir Biotechnology's Debt Ratio history spans 5 years, with the latest figure at 0.01 for Q1 2025.

  • On a quarterly basis, Debt Ratio changed N/A to 0.01 in Q1 2025 year-over-year; TTM through Mar 2025 was 0.01, a N/A change, with the full-year FY2024 number at 0.01, changed N/A from a year prior.
  • Debt Ratio hit 0.01 in Q1 2025 for Vir Biotechnology, up from 0.01 in the prior quarter.
  • Over the last five years, Debt Ratio for VIR hit a ceiling of 0.06 in Q3 2021 and a floor of 0.01 in Q4 2024.
  • Historically, Debt Ratio has averaged 0.03 across 3 years, with a median of 0.02 in 2021.
  • The widest YoY moves for Debt Ratio: up 254.33% in 2021, down 4.19% in 2021.
  • Tracing VIR's Debt Ratio over 3 years: stood at 0.06 in 2021, then plummeted by 79.72% to 0.01 in 2024, then grew by 16.56% to 0.01 in 2025.
  • Business Quant data shows Debt Ratio for VIR at 0.01 in Q1 2025, 0.01 in Q4 2024, and 0.06 in Q3 2021.